Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN
Hartmut Döhner(University Hospital Ulm), Bob Löwenberg(Unknown), Andrew H. Wei(The Royal Melbourne Hospital), Courtney D. DiNardo(The University of Texas MD Anderson Cancer Center), Pierre Fenaux(Saint Louis University Hospital), Agnieszka Wierzbowska(Medical University of Lodz), Ross L. Levine(Memorial Sloan Kettering Cancer Center), Jorge Sierra(Universitat Autònoma de Barcelona), Christoph Röllig(University Hospital Carl Gustav Carus), Robert P. Hasserjian(Massachusetts General Hospital), Hwei‐Fang Tien(Far Eastern Memorial Hospital), Dietger Niederwieser(Leipzig University of Applied Sciences), Frederick R. Appelbaum(Cape Town HVTN Immunology Laboratory / Hutchinson Centre Research Institute of South Africa), Lucy A. Godley(University of Chicago), Eytan M. Stein(Memorial Sloan Kettering Cancer Center), Benjamin L. Ebert(Dana-Farber Cancer Institute), Yasushi Miyazaki(Nagasaki University), Richard A. Larson(Urbana University), Charles Craddock(University Hospitals Birmingham NHS Foundation Trust), Jianxiang Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hervé Dombret(Université Paris Cité), Gert J. Ossenkoppele(Dutch Cancer Society), Martin S. Tallman(Memorial Sloan Kettering Cancer Center)
Cited by 2,987
Related Papers
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
|Proceedings of the National Academy of Sciences|2005|56.5k
Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
|Blood|2016|5.9k
Genomic Classification and Prognosis in Acute Myeloid Leukemia
|New England Journal of Medicine|2016|4.4k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k